Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy

Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy

Rheumatoid arthritis (RA) is an inflammatory immune-mediated disease that can lead to synovitis, cartilage destruction, and even joint damage. Dexamethasone (DEX) is a commonly used agent for RA therapy on inflammation manage. However, the traditional administering DEX is hampered by low efficiency...

Full description

Bibliographic Details
Main Authors: Yi-Pu Zhao, Jiang-Fan Han, Fei-Yue Zhang, Tian-Tian Liao, Ren Na, Xiao-Feng Yuan, Guang-bin He, Weiliang Ye
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Drug Delivery
Subjects:
Transdermal drug delivery system
dextran sulfate
flexible liposome
rheumatoid arthritis
Online Access:https://www.tandfonline.com/doi/10.1080/10717544.2022.2096718

Internet

https://www.tandfonline.com/doi/10.1080/10717544.2022.2096718

Similar Items